Strengthening Translational Research in India: GVSAP and Biocytogen Expand Collaboration
Feb 05, 2026
Hyderabad (Telangana) [India], February 5: GV Safety Assessment Platform (GVSAP), an integrated preclinical R&D enabler within the GVRP portfolio, today announced an expansion of its strategic collaboration with Biocytogen (SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. This move significantly bolsters access to advanced biomedical research tools for India's burgeoning biopharma ecosystem.
Read More ..
